Insider Profile
West, Derrick
1
Companies Filed At
0
Open-Market Buys (2yr)
Buy Value (2yr, open-market)
Sep 29, 2022
Most Recent Trade
13
Credibility
Score
57%
Hit Rate
+9.3%
Avg 90d Return
+9.8%
Median 90d Return
7
Evaluated Trades
+34.8%
Best Trade
-21.1%
Worst Trade
Hit rate and returns are based on 7 open-market buys with evaluable 90-day outcomes. Score reflects historical conviction, not a guarantee of future performance. Limited signal — either below-average timing or insufficient trade history.
Cross-Company Track Record
THIN HISTORY
50%
Hit Rate · 90d
+3.0%
Median Alpha · 90d
2
Closed Buys Evaluated
50%
Beat XIU
All-insider base rate: 59% hit rate  · +1.3% mean alpha (n=11504)
size concentrated
Entry: closing price on SEDI filing date (point-in-time). Exit: 90 calendar days later. Alpha vs XIU.TO (iShares TSX 60). Closed trades only. Not investment advice.
Research 2 closed buys with individual return outcomes available on the Research plan.
Date Company Role Nature Dir. Shares Price Value Score
Sep 29, 2022 $OGI
Organigram Holdings
Comp. Grant Buy 51,575 $1.23 $63K 70
Sep 29, 2022 $OGI
Organigram Holdings
Comp. Grant Buy 51,575 $1.23 $63K 70
May 24, 2022 $OGI
Organigram Holdings
Open Market Buy 4,035 $1.46 $6K 70
Jan 18, 2021 $OGI
Organigram Holdings
Comp. Grant Buy 50,000 $2.19 $110K 70
Jan 15, 2021 $OGI
Organigram Holdings
Comp. Grant Buy 28,820 $2.15 $62K 70
Jan 15, 2021 $OGI
Organigram Holdings
Comp. Grant Buy 9,606 $2.15 $21K 70
Mar 13, 2020 $OGI
Organigram Holdings
Open Market Buy 2,900 $2.01 $6K 70
Muted rows are plan purchases, compensation grants, or DRIP — not open-market. Confluence Scores reflect the company's current score, not the score at time of trade.
Form55 provides data and analysis for informational purposes only. Nothing on this site constitutes investment advice or a recommendation to buy or sell any security. Past performance is not indicative of future results.